KSHV Reactivation from Latency Requires Pim-1 and Pim-3 Kinases to Inactivate the Latency-Associated Nuclear Antigen LANA

Host signal-transduction pathways are intimately involved in the switch between latency and productive infection of herpes viruses. As with other herpes viruses, infection by Kaposi's sarcoma herpesvirus (KSHV) displays these two phases. During latency only few viral genes are expressed, while in the productive infection the virus is reactivated with initiation of extensive viral DNA replication and gene expression, resulting in production of new viral particles. Viral reactivation is crucial for KSHV pathogenesis and contributes to the progression of KS. We have recently identified Pim-1 as a kinase reactivating KSHV upon over-expression. Here we show that another Pim family kinase, Pim-3, also induces viral reactivation. We demonstrate that expression of both Pim-1 and Pim-3 is induced in response to physiological and chemical reactivation in naturally KSHV-infected cells, and we show that they are required for KSHV reactivation under these conditions. Furthermore, our data indicate that Pim-1 and Pim-3 contribute to viral reactivation by phosphorylating the KSHV latency-associated nuclear antigen (LANA) on serine residues 205 and 206. This counteracts the LANA–mediated repression of the KSHV lytic gene transcription. The identification of Pim family kinases as novel cellular regulators of the gammaherpesvirus life cycle facilitates a deeper understanding of virus–host interactions during reactivation and may represent potential novel targets for therapeutic intervention.

[1]  W. Zhu,et al.  Potential Cellular Signatures of Viral Infections in Human Hematopoietic Cells , 2002, Disease markers.

[2]  D. Ganem,et al.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. , 2004, The Journal of clinical investigation.

[3]  Shou-Jiang Gao,et al.  Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. , 2008, Virology.

[4]  D. Ganem,et al.  Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. , 1997, The Journal of clinical investigation.

[5]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[6]  R. Sarid,et al.  An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus. , 2006, The Journal of general virology.

[7]  P. Lieberman,et al.  Acetylation of the Latency-Associated Nuclear Antigen Regulates Repression of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription , 2006, Journal of Virology.

[8]  J. Vieira,et al.  Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. , 2004, Virology.

[9]  S. Verma,et al.  Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Inhibits Lytic Replication by Targeting Rta: a Potential Mechanism for Virus-Mediated Control of Latency , 2004, Journal of Virology.

[10]  L. Rainbow,et al.  The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen , 1997, Journal of virology.

[11]  B. Chandran,et al.  Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. , 2000, The American journal of pathology.

[12]  A. Haase,et al.  A Cluster of Latently Expressed Genes in Kaposi’s Sarcoma-Associated Herpesvirus , 1998, Journal of Virology.

[13]  Sami Kilpinen,et al.  Application of Active and Kinase-Deficient Kinome Collection for Identification of Kinases Regulating Hedgehog Signaling , 2008, Cell.

[14]  Jos Jonkers,et al.  Mice Deficient for All PIM Kinases Display Reduced Body Size and Impaired Responses to Hematopoietic Growth Factors , 2004, Molecular and Cellular Biology.

[15]  Jianhong Hu,et al.  Latency-associated Nuclear Antigen (LANA) Cooperatively Binds to Two Sites within the Terminal Repeat, and Both Sites Contribute to the Ability of LANA to Suppress Transcription and to Facilitate DNA Replication* , 2002, The Journal of Biological Chemistry.

[16]  M. Corbellino,et al.  Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. , 2000, The American journal of pathology.

[17]  F. Sigaux,et al.  The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Shou-Jiang Gao,et al.  Disruption of Kaposi's Sarcoma-Associated Herpesvirus Latent Nuclear Antigen Leads to Abortive Episome Persistence , 2004, Journal of Virology.

[19]  J. Levy,et al.  Induction of human herpesvirus-8 gene expression by recombinant interferon gamma. , 2000, AIDS.

[20]  P. Ojala,et al.  Cell signaling pathways engaged by KSHV. , 2006, Biochimica et biophysica acta.

[21]  D. Ganem,et al.  The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. , 2002, Genes & development.

[22]  P. Monini,et al.  Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. , 1999, Blood.

[23]  S. Verma,et al.  KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity. , 2006, Virology.

[24]  T. Schulz,et al.  Brd2/RING3 Interacts with a Chromatin-Binding Domain in the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 (LANA-1) That Is Required for Multiple Functions of LANA-1 , 2005, Journal of Virology.

[25]  D. Dittmer,et al.  Charting Latency Transcripts in Kaposi's Sarcoma-Associated Herpesvirus by Whole-Genome Real-Time Quantitative PCR , 2002, Journal of Virology.

[26]  P. Monini,et al.  Reactivation and role of HHV-8 in Kaposi's sarcoma initiation. , 2001, Advances in cancer research.

[27]  S. Chanda,et al.  Systematic Identification of Cellular Signals Reactivating Kaposi Sarcoma–Associated Herpesvirus , 2007, PLoS pathogens.

[28]  Jianhong Hu,et al.  DNA Binding and Modulation of Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.

[29]  R. Sun,et al.  Regulation of KSHV lytic gene expression. , 2007, Current topics in microbiology and immunology.

[30]  K. Hagihara,et al.  Viral Load of Human Herpesvirus 8 (HHV-8) in the Circulatory Blood Cells Correlates with Clinical Progression in a Patient with HHV-8-associated Solid Lymphoma with AIDS-associated Kaposi's Sarcoma , 2004, Leukemia & lymphoma.

[31]  B. Ensoli,et al.  Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology. , 1998, Critical reviews in oncogenesis.

[32]  E. Cesarman,et al.  Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, Diseases , 2002, Clinical Microbiology Reviews.

[33]  Remco Dijkman,et al.  Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. , 2005, Blood.

[34]  R. Sun,et al.  Transcription Activation of Polyadenylated Nuclear RNA by Rta in Human Herpesvirus 8/Kaposi's Sarcoma-Associated Herpesvirus , 2001, Journal of Virology.

[35]  D. Dittmer Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. , 2003, Cancer research.

[36]  C. Thompson,et al.  The survival kinases Akt and Pim as potential pharmacological targets. , 2005, The Journal of clinical investigation.

[37]  E. Kieff,et al.  Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity. , 2005, Virology.

[38]  M. Staudt,et al.  The Rta/Orf50 transactivator proteins of the gamma-herpesviridae. , 2007, Current topics in microbiology and immunology.

[39]  T. Möröy,et al.  The serine/threonine kinase Pim-1. , 2005, The international journal of biochemistry & cell biology.

[40]  E. Robertson,et al.  Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency. , 2006, Virology.

[41]  M. Ballestas,et al.  Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. , 1999, Science.

[42]  R. Sun,et al.  Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus. , 2000, The Journal of general virology.

[43]  D. Dittmer,et al.  Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. , 2000, Virology.

[44]  J. Countryman,et al.  Lytic cycle switches of oncogenic human gammaherpesviruses. , 2007, Advances in cancer research.

[45]  Stefan Knapp,et al.  Structure and Substrate Specificity of the Pim-1 Kinase* , 2005, Journal of Biological Chemistry.

[46]  T. Schulz,et al.  Human herpesvirus 8: Biology and role in the pathogenesis of Kaposi’s sarcoma and other AIDS-related malignancies , 2003, Current infectious disease reports.

[47]  S. Verma,et al.  Latency-Associated Nuclear Antigen (LANA) of Kaposi's Sarcoma-Associated Herpesvirus Interacts with Origin Recognition Complexes at the LANA Binding Sequence within the Terminal Repeats , 2006, Journal of Virology.